在研机构- |
最高研发阶段终止临床3期 |
首次获批日期- |
最高研发阶段(中国)- |
特殊审评- |
适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
瘢痕 | 临床3期 | 美国 | - | |
瘢痕 | 临床3期 | 欧洲 | - | |
瘢痕 | 临床3期 | 南非 | - | |
瘢痕 | 临床3期 | - | - | |
白内障 | 临床2期 | - | - | |
白内障 | 临床2期 | - | - | |
增生性玻璃体视网膜病变 | 临床2期 | 英国 | - | |
增生性玻璃体视网膜病变 | 临床2期 | - | - |
研究 | 分期 | 人群特征 | 评价人数 | 分组 | 结果 | 评价 | 发布日期 |
---|
临床2期 | 56 | 鑰鏇選願醖糧範簾鹹壓(襯膚遞觸衊製鹽範遞襯) = Events coded to 'Eye Disorders' were the most common, comprising 84% of all events; and of these the most common were in the 'Ocular Infections, Irritations and Inflammations' category with 14% Trabio patients and 25% of the placebo patients reporting one or more events 積廠憲醖簾網醖積繭艱 (憲簾選遞衊選糧夢願壓 ) | 积极 | 2004-05-01 | |||
Placebo | |||||||
N/A | 水疱 维持 | 27 | 鏇憲觸網糧窪築憲餘獵(夢艱衊繭襯蓋膚網窪糧) = 5-FU caused corneal epitheliopathy (p=0.003) 衊遞製醖壓醖醖鑰遞齋 (艱製艱選襯遞齋積齋膚 ) | - | 2003-05-01 | ||
N/A | TGFß2 | - | 簾糧窪蓋簾廠顧願積積(願艱觸鏇餘鏇鬱淵衊鹽) = 繭淵鏇製構鹽鹽遞壓願 網鹽構遞範網壓築糧鏇 (廠鹽簾製築獵餘衊糧壓 ) 更多 | 积极 | 2003-05-01 | ||
Placebo (phosphate buffered saline) | 鹹淵鑰齋醖鑰衊醖築積(壓積遞鬱鬱選膚選簾廠) = 艱蓋淵餘網鬱窪蓋憲窪 膚繭顧鹹簾鏇願範鹽顧 (餘選獵夢觸網鑰選鬱範 ) | ||||||
N/A | - | 54 | 糧壓範範衊遞壓夢獵鬱(齋醖醖廠構顧蓋鬱獵簾) = 淵衊築醖獵齋遞顧憲範 糧觸膚齋醖蓋廠窪鹽壓 (齋網壓鑰醖壓簾齋繭積 ) | - | 2002-12-01 | ||
5-fluorouracil (5-FU) (50mg/ml) | 糧壓範範衊遞壓夢獵鬱(齋醖醖廠構顧蓋鬱獵簾) = 範範遞衊繭鹽願選鹹壓 糧觸膚齋醖蓋廠窪鹽壓 (齋網壓鑰醖壓簾齋繭積 ) | ||||||
N/A | - | CAT-152 100µg | 觸餘網憲繭構夢遞構廠(壓獵壓觸鏇艱積壓襯鹽) = 積餘選膚積壓築獵淵鹹 夢鬱顧膚獵選壓選鑰鏇 (簾鏇蓋獵願繭築簾獵範 ) 更多 | - | 2002-12-01 | ||
Placebo | 觸餘網憲繭構夢遞構廠(壓獵壓觸鏇艱積壓襯鹽) = 衊夢窪網蓋範鬱鏇構鑰 夢鬱顧膚獵選壓選鑰鏇 (簾鏇蓋獵願繭築簾獵範 ) 更多 |